Please enable JavaScript to continue using this application.

Compare $CYTK vs $KRYS | Chartloom

Compare

$CYTK vs $KRYS

Cytokinetics Inc · Krystal Biotech Inc

CYTK

Cytokinetics Inc

KRYS

Krystal Biotech Inc

Compare $CYTK vs $KRYS

Comparing Cytokinetics Inc and Krystal Biotech Inc

CYTKCytokinetics Inc

KRYSKrystal Biotech Inc

CYTKCytokinetics Inc

Market cap

$8.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

33.61x

Rev growth (TTM)

-21.1%

YTD performance

1.9%

52W performance

3.4%

FCF yield

-6.8%

KRYSKrystal Biotech Inc

Market cap

$9.78B

P/E (TTM)

42.10x

Forward P/E (NTM)

39.13x

Forward P/S (NTM)

16.80x

Rev growth (TTM)

22.6%

YTD performance

34.3%

52W performance

77.2%

FCF yield

2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYTK

KRYS

Detailed metrics comparison

CYTK

Cytokinetics Inc

KRYS

Krystal Biotech Inc

Market Cap

CYTK$8.53B

KRYS$9.78B

Enterprise Value

CYTK$9.42B

KRYS$9.35B

Price

CYTK$62.91

KRYS$331.61

P/E Ratio

CYTKN/A

KRYS42.10x

P/S Ratio

CYTK126.04x

KRYS22.19x

EV/Sales

CYTK139.22x

KRYS21.22x

EV/EBITDA

CYTK1,193.30x

KRYS42.60x

P/B Ratio

CYTK83.67x

KRYS7.02x

P/FCF Ratio

CYTKN/A

KRYS37.92x

EV/FCF

CYTK-16.22x

KRYS36.26x

PEG Ratio

CYTKN/A

KRYS1.01x

Forward P/E (NTM)

CYTKN/A

KRYS39.13x

Forward P/S (NTM)

CYTK33.61x

KRYS16.80x

Revenue (TTM)

CYTK$68M

KRYS$440M

Revenue Growth (YoY)

CYTK-21.1%

KRYS22.6%

Forward Rev Growth

CYTK183.7%

KRYS27.8%

Gross Margin (TTM)

CYTK58.9%

KRYS94.6%

Operating Margin (TTM)

CYTK0.0%

KRYS44.9%

EBITDA Margin (TTM)

CYTK-1027.6%

KRYS46.2%

Net Margin (TTM)

CYTK-1321.1%

KRYS54.8%

FCF Margin (TTM)

CYTK-858.2%

KRYS58.5%

Net Income (TTM)

CYTK$-894M

KRYS$241M

FCF (TTM)

CYTK$-581M

KRYS$258M

EPS (TTM)

CYTK-$6.77

KRYS$7.88

ROE (TTM)

CYTK-13119.0%

KRYS19.3%

ROA (TTM)

CYTK-5902.0%

KRYS17.6%

ROIC (TTM)

CYTK-1872.0%

KRYS19.3%

Cash

CYTK$255M

KRYS$428M

Debt

CYTK$1.15B

KRYS$0

Net Cash/Debt

CYTK$-892M

KRYS$428M

Current Ratio (TTM)

CYTK6.66x

KRYS8.32x

Quick Ratio (TTM)

CYTK6.56x

KRYS7.73x

Debt/Equity (TTM)

CYTK6.01x

KRYS0.00x

Debt/Assets (TTM)

CYTK0.0%

KRYS0.0%

Interest Coverage (TTM)

CYTKN/A

KRYSN/A

Net Debt/EBITDA (TTM)

CYTK0.00x

KRYS0.00x

Beta

CYTK0.42

KRYS0.65

52W Performance

CYTK3.4%

KRYS77.2%

YTD Performance

CYTK1.9%

KRYS34.3%

% from 52W High

CYTK-28.8%

KRYS-13.3%

% from 52W Low

CYTK15.9%

KRYS85.1%

Asset Turnover (TTM)

CYTK0.04x

KRYS0.32x

FCF Yield (TTM)

CYTK-6.8%

KRYS2.6%

Earnings Yield (TTM)

CYTK-10.5%

KRYS2.5%

Dividend Yield (TTM)

CYTKN/A

KRYSN/A

Rule of 40

CYTK-879.2

KRYS81.1

EV/GP/RG

CYTK0.73

KRYS0.65

Ticker research

View CYTK research View KRYS research

Metric	CYTK Cytokinetics Inc	KRYS Krystal Biotech Inc
Market & Valuation
Market Cap	$8.53B	$9.78B
Enterprise Value	$9.42B	$9.35B
Price	$62.91	$331.61
P/E Ratio	N/A	42.10x
P/S Ratio	126.04x	22.19x
EV/Sales	139.22x	21.22x
EV/EBITDA	1,193.30x	42.60x
P/B Ratio	83.67x	7.02x
P/FCF Ratio	N/A	37.92x
EV/FCF	-16.22x	36.26x
PEG Ratio	N/A	1.01x
Forward P/E (NTM)	N/A	39.13x
Forward P/S (NTM)	33.61x	16.80x
Revenue & Growth
Revenue (TTM)	$68M	$440M
Revenue Growth (YoY)	-21.1%	22.6%
Forward Rev Growth	183.7%	27.8%
Profitability
Gross Margin (TTM)	58.9%	94.6%
Operating Margin (TTM)	0.0%	44.9%
EBITDA Margin (TTM)	-1027.6%	46.2%
Net Margin (TTM)	-1321.1%	54.8%
FCF Margin (TTM)	-858.2%	58.5%
Net Income (TTM)	$-894M	$241M
FCF (TTM)	$-581M	$258M
EPS (TTM)	-$6.77	$7.88
ROE (TTM)	-13119.0%	19.3%
ROA (TTM)	-5902.0%	17.6%
ROIC (TTM)	-1872.0%	19.3%
Financial Health
Cash	$255M	$428M
Debt	$1.15B	$0
Net Cash/Debt	$-892M	$428M
Current Ratio (TTM)	6.66x	8.32x
Quick Ratio (TTM)	6.56x	7.73x
Debt/Equity (TTM)	6.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.42	0.65
52W Performance	3.4%	77.2%
YTD Performance	1.9%	34.3%
% from 52W High	-28.8%	-13.3%
% from 52W Low	15.9%	85.1%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.32x
FCF Yield (TTM)	-6.8%	2.6%
Earnings Yield (TTM)	-10.5%	2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-879.2	81.1
EV/GP/RG	0.73	0.65
Ticker research	View CYTK research	View KRYS research

Valuation

P/E Ratio

KRYS

42.10x

P/S Ratio

KRYS

22.19x

CYTK

126.04x

EV/FCF

CYTK

-16.22x

KRYS

36.26x

Growth & revenue

Revenue Growth TTM

KRYS

22.6%

CYTK

-21.1%

Forward Revenue Growth

CYTK

183.7%

KRYS

27.8%

Profitability & performance

Gross Margin

KRYS

94.6%

CYTK

58.9%

ROE

KRYS

19.3%

CYTK

-13119.0%

FCF Yield %

KRYS

2.6%

CYTK

-6.8%

52-Week Performance

KRYS

77.2%

CYTK

3.4%

Detailed metrics comparison

CYTK

Cytokinetics Inc

KRYS

Krystal Biotech Inc

Market Cap

CYTK$8.53B

KRYS$9.78B

Enterprise Value

CYTK$9.42B

KRYS$9.35B

Price

CYTK$62.91

KRYS$331.61

P/E Ratio

CYTKN/A

KRYS42.10x

P/S Ratio

CYTK126.04x

KRYS22.19x

EV/Sales

CYTK139.22x

KRYS21.22x

EV/EBITDA

CYTK1,193.30x

KRYS42.60x

P/B Ratio

CYTK83.67x

KRYS7.02x

P/FCF Ratio

CYTKN/A

KRYS37.92x

EV/FCF

CYTK-16.22x

KRYS36.26x

PEG Ratio

CYTKN/A

KRYS1.01x

Forward P/E (NTM)

CYTKN/A

KRYS39.13x

Forward P/S (NTM)

CYTK33.61x

KRYS16.80x

Revenue (TTM)

CYTK$68M

KRYS$440M

Revenue Growth (YoY)

CYTK-21.1%

KRYS22.6%

Forward Rev Growth

CYTK183.7%

KRYS27.8%

Gross Margin (TTM)

CYTK58.9%

KRYS94.6%

Operating Margin (TTM)

CYTK0.0%

KRYS44.9%

EBITDA Margin (TTM)

CYTK-1027.6%

KRYS46.2%

Net Margin (TTM)

CYTK-1321.1%

KRYS54.8%

FCF Margin (TTM)

CYTK-858.2%

KRYS58.5%

Net Income (TTM)

CYTK$-894M

KRYS$241M

FCF (TTM)

CYTK$-581M

KRYS$258M

EPS (TTM)

CYTK-$6.77

KRYS$7.88

ROE (TTM)

CYTK-13119.0%

KRYS19.3%

ROA (TTM)

CYTK-5902.0%

KRYS17.6%

ROIC (TTM)

CYTK-1872.0%

KRYS19.3%

Cash

CYTK$255M

KRYS$428M

Debt

CYTK$1.15B

KRYS$0

Net Cash/Debt

CYTK$-892M

KRYS$428M

Current Ratio (TTM)

CYTK6.66x

KRYS8.32x

Quick Ratio (TTM)

CYTK6.56x

KRYS7.73x

Debt/Equity (TTM)

CYTK6.01x

KRYS0.00x

Debt/Assets (TTM)

CYTK0.0%

KRYS0.0%

Interest Coverage (TTM)

CYTKN/A

KRYSN/A

Net Debt/EBITDA (TTM)

CYTK0.00x

KRYS0.00x

Beta

CYTK0.42

KRYS0.65

52W Performance

CYTK3.4%

KRYS77.2%

YTD Performance

CYTK1.9%

KRYS34.3%

% from 52W High

CYTK-28.8%

KRYS-13.3%

% from 52W Low

CYTK15.9%

KRYS85.1%

Asset Turnover (TTM)

CYTK0.04x

KRYS0.32x

FCF Yield (TTM)

CYTK-6.8%

KRYS2.6%

Earnings Yield (TTM)

CYTK-10.5%

KRYS2.5%

Dividend Yield (TTM)

CYTKN/A

KRYSN/A

Rule of 40

CYTK-879.2

KRYS81.1

EV/GP/RG

CYTK0.73

KRYS0.65

Ticker research

View CYTK research View KRYS research

Metric	CYTK Cytokinetics Inc	KRYS Krystal Biotech Inc
Market & Valuation
Market Cap	$8.53B	$9.78B
Enterprise Value	$9.42B	$9.35B
Price	$62.91	$331.61
P/E Ratio	N/A	42.10x
P/S Ratio	126.04x	22.19x
EV/Sales	139.22x	21.22x
EV/EBITDA	1,193.30x	42.60x
P/B Ratio	83.67x	7.02x
P/FCF Ratio	N/A	37.92x
EV/FCF	-16.22x	36.26x
PEG Ratio	N/A	1.01x
Forward P/E (NTM)	N/A	39.13x
Forward P/S (NTM)	33.61x	16.80x
Revenue & Growth
Revenue (TTM)	$68M	$440M
Revenue Growth (YoY)	-21.1%	22.6%
Forward Rev Growth	183.7%	27.8%
Profitability
Gross Margin (TTM)	58.9%	94.6%
Operating Margin (TTM)	0.0%	44.9%
EBITDA Margin (TTM)	-1027.6%	46.2%
Net Margin (TTM)	-1321.1%	54.8%
FCF Margin (TTM)	-858.2%	58.5%
Net Income (TTM)	$-894M	$241M
FCF (TTM)	$-581M	$258M
EPS (TTM)	-$6.77	$7.88
ROE (TTM)	-13119.0%	19.3%
ROA (TTM)	-5902.0%	17.6%
ROIC (TTM)	-1872.0%	19.3%
Financial Health
Cash	$255M	$428M
Debt	$1.15B	$0
Net Cash/Debt	$-892M	$428M
Current Ratio (TTM)	6.66x	8.32x
Quick Ratio (TTM)	6.56x	7.73x
Debt/Equity (TTM)	6.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.42	0.65
52W Performance	3.4%	77.2%
YTD Performance	1.9%	34.3%
% from 52W High	-28.8%	-13.3%
% from 52W Low	15.9%	85.1%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.32x
FCF Yield (TTM)	-6.8%	2.6%
Earnings Yield (TTM)	-10.5%	2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-879.2	81.1
EV/GP/RG	0.73	0.65
Ticker research	View CYTK research	View KRYS research